Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 182 articles:
HTML format



Single Articles


    September 2021
  1. YANG J, Yan Z, Wang Y, Xu J, et al
    Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
    BMC Cancer. 2021;21:997.
    PubMed     Abstract available


    August 2021
  2. LIU J, Liu X, Guo Z, Lv X, et al
    Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making.
    BMC Cancer. 2021;21:964.
    PubMed     Abstract available


  3. BONI SP, Gnahatin F, Comoe JC, Tchounga B, et al
    Barriers and facilitators in cervical cancer screening uptake in Abidjan, Cote d'Ivoire in 2018: a cross-sectional study.
    BMC Cancer. 2021;21:952.
    PubMed     Abstract available


  4. HANSEN BT, Campbell S, Nygard M
    Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study.
    BMC Cancer. 2021;21:935.
    PubMed     Abstract available


  5. WU B, Xi S
    Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    BMC Cancer. 2021;21:928.
    PubMed     Abstract available


    July 2021
  6. KIM JY, Lee DW, Kim MJ, Shin JE, et al
    Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018).
    BMC Cancer. 2021;21:880.
    PubMed     Abstract available


  7. QI J, Zhou L, Li D, Yang J, et al
    Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A.
    BMC Cancer. 2021;21:819.
    PubMed     Abstract available


  8. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:811.
    PubMed    


    June 2021
  9. WU B, Xi S
    Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    BMC Cancer. 2021;21:733.
    PubMed     Abstract available


  10. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
    Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
    BMC Cancer. 2021;21:682.
    PubMed     Abstract available


  11. ZHAO J, Cao H, Zhang W, Fan Y, et al
    SOX14 hypermethylation as a tumour biomarker in cervical cancer.
    BMC Cancer. 2021;21:675.
    PubMed     Abstract available


  12. RAKHSHANDA S, Dalal K, Chowdhury HA, Mayaboti CA, et al
    Assessing service availability and readiness to manage cervical cancer in Bangladesh.
    BMC Cancer. 2021;21:670.
    PubMed     Abstract available


  13. ZOU D, Guo M, Zhou Q
    A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
    BMC Cancer. 2021;21:661.
    PubMed     Abstract available


    May 2021
  14. DENG ZM, Dai FF, Zhou Q, Cheng YX, et al
    Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis.
    BMC Cancer. 2021;21:583.
    PubMed     Abstract available


  15. CHEN HH, Meng WY, Li RZ, Wang QY, et al
    Potential prognostic factors in progression-free survival for patients with cervical cancer.
    BMC Cancer. 2021;21:531.
    PubMed     Abstract available


  16. LI W, Xiong L, Zhu Q, Lu H, et al
    Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
    BMC Cancer. 2021;21:484.
    PubMed     Abstract available


    April 2021
  17. FENG Y, Wang Y, Xie Y, Wu S, et al
    Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    BMC Cancer. 2021;21:450.
    PubMed     Abstract available


  18. LEE F, Bula A, Chapola J, Mapanje C, et al
    Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
    BMC Cancer. 2021;21:428.
    PubMed     Abstract available


  19. LI Y, Chen Z, Wang X, Li X, et al
    Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.
    BMC Cancer. 2021;21:442.
    PubMed     Abstract available


  20. LIU H, Ye X, Li D, Yao Q, et al
    Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study.
    BMC Cancer. 2021;21:421.
    PubMed     Abstract available


  21. MA D, Pan Z, Chang Q, Zhang JJ, et al
    KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
    BMC Cancer. 2021;21:377.
    PubMed     Abstract available


  22. TISLER A, Ojavee SE, Veerus P, Soodla P, et al
    Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
    BMC Cancer. 2021;21:350.
    PubMed     Abstract available


    March 2021
  23. ZHANG SW, Luo RZ, Sun XY, Yang X, et al
    Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
    BMC Cancer. 2021;21:332.
    PubMed     Abstract available


  24. SHARMIN S, Zohura FT, Islam MS, Shimonty A, et al
    Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    BMC Cancer. 2021;21:289.
    PubMed     Abstract available


  25. GAETE S, Auguste A, Bhakkan B, Peruvien J, et al
    Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
    BMC Cancer. 2021;21:281.
    PubMed     Abstract available


  26. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
    Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    BMC Cancer. 2021;21:264.
    PubMed     Abstract available


  27. JU Z, Guo W, Gu S, Zhou J, et al
    CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy.
    BMC Cancer. 2021;21:243.
    PubMed     Abstract available


  28. ARARSA T, Tadele N, Ayalew Y, Gela D, et al
    Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey.
    BMC Cancer. 2021;21:224.
    PubMed     Abstract available


    February 2021
  29. YANG E, Huang S, Ran X, Huang Y, et al
    The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    BMC Cancer. 2021;21:203.
    PubMed     Abstract available


  30. CHU G, Liu X, Yu W, Chen M, et al
    Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study.
    BMC Cancer. 2021;21:133.
    PubMed     Abstract available


  31. GOUY S, Seebacher V, Chargari C, Terroir M, et al
    False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
    BMC Cancer. 2021;21:135.
    PubMed     Abstract available


  32. OBOL JH, Lin S, Obwolo MJ, Harrison R, et al
    Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
    BMC Cancer. 2021;21:110.
    PubMed     Abstract available


  33. CHI RA, van der Watt P, Wei W, Birrer MJ, et al
    Inhibition of Kpnbeta1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
    BMC Cancer. 2021;21:106.
    PubMed     Abstract available


    January 2021
  34. DEL MORAL-HERNANDEZ O, Hernandez-Sotelo D, Alarcon-Romero LDC, Mendoza-Catalan MA, et al
    TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    BMC Cancer. 2021;21:39.
    PubMed     Abstract available


    December 2020
  35. BAO H, Wang L, Brown M, Zhang M, et al
    A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities.
    BMC Cancer. 2020;20:1191.
    PubMed     Abstract available


    November 2020
  36. TAKEKUMA M, Takahashi F, Mabuchi S, Kudaka W, et al
    Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.
    BMC Cancer. 2020;20:1169.
    PubMed     Abstract available


  37. CAI L, Hu C, Yu S, Liu L, et al
    Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.
    BMC Cancer. 2020;20:1133.
    PubMed     Abstract available


  38. PITTALIS C, Panteli E, Schouten E, Magongwa I, et al
    Breast and cervical cancer screening services in Malawi: a systematic review.
    BMC Cancer. 2020;20:1101.
    PubMed     Abstract available


  39. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Gil Quijano AM, Valbuena AM, et al
    Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis.
    BMC Cancer. 2020;20:1097.
    PubMed     Abstract available


  40. BANU N, Riera-Leal A, Haramati J, Ortiz-Lazareno PC, et al
    B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
    BMC Cancer. 2020;20:1083.
    PubMed     Abstract available


    October 2020
  41. LIU J, Li Y, Chen X, Xu X, et al
    Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.
    BMC Cancer. 2020;20:1029.
    PubMed     Abstract available


    September 2020
  42. GESINK MP, Chamberlain RM, Mwaiselage J, Kahesa C, et al
    Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
    BMC Cancer. 2020;20:939.
    PubMed     Abstract available


  43. CHEN M, Wang H, Liang Y, Hu M, et al
    Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
    BMC Cancer. 2020;20:926.
    PubMed     Abstract available


  44. CHEN S, Li K
    HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    BMC Cancer. 2020;20:924.
    PubMed     Abstract available


  45. YAO T, Weng X, Yao Y, Huang C, et al
    ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer.
    BMC Cancer. 2020;20:891.
    PubMed     Abstract available


  46. HAILEMARIAM G, Gebreyesus H, Wubayehu T, Gebregyorgis T, et al
    Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25-49 years in North Ethiopia.
    BMC Cancer. 2020;20:858.
    PubMed     Abstract available


  47. XIE G, Wang R, Shang L, Qi C, et al
    Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
    BMC Cancer. 2020;20:833.
    PubMed     Abstract available


  48. ABDALLA E, Troy R, Fall S, Elhussin I, et al
    Racial differences in 5-year relative survival rates of cervical cancer by stage at diagnosis, between African American (black) and white women, living in the state of Alabama, USA.
    BMC Cancer. 2020;20:830.
    PubMed     Abstract available


    August 2020
  49. ZHAO D, Zhang L, Xie F, Peng D, et al
    Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    BMC Cancer. 2020;20:810.
    PubMed     Abstract available


  50. DIAO W, Guo Q, Zhu C, Song Y, et al
    USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
    BMC Cancer. 2020;20:741.
    PubMed     Abstract available


  51. MATSUOKA H, Murakami R, Abiko K, Yamaguchi K, et al
    UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study.
    BMC Cancer. 2020;20:729.
    PubMed     Abstract available


    July 2020
  52. TESFAW G, Ahmed Y, Gedefaw L, Dube L, et al
    Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia.
    BMC Cancer. 2020;20:706.
    PubMed     Abstract available


  53. LEE SY, Chae DK, Lee SH, Lim Y, et al
    Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    BMC Cancer. 2020;20:694.
    PubMed     Abstract available


  54. AN Q, Liu W, Yang Y, Yang B, et al
    Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer.
    BMC Cancer. 2020;20:691.
    PubMed     Abstract available


  55. ZHANG X, Lv Z, Xu X, Yin Z, et al
    Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
    BMC Cancer. 2020;20:664.
    PubMed     Abstract available


  56. AZEVEDO MARTINS JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC, et al
    Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    BMC Cancer. 2020;20:660.
    PubMed     Abstract available


  57. AARNIO R, Ostensson E, Olovsson M, Gustavsson I, et al
    Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    BMC Cancer. 2020;20:645.
    PubMed     Abstract available


    June 2020
  58. KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
    Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
    BMC Cancer. 2020;20:577.
    PubMed     Abstract available


  59. RUDDIES F, Gizaw M, Teka B, Thies S, et al
    Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study.
    BMC Cancer. 2020;20:563.
    PubMed     Abstract available


  60. ITO M, Kodaira T, Koide Y, Okuda T, et al
    Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
    BMC Cancer. 2020;20:540.
    PubMed     Abstract available


  61. VAN DE LAAR RLO, Hofhuis W, Duijnhoven RG, Polinder S, et al
    Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    BMC Cancer. 2020;20:539.
    PubMed     Abstract available


    May 2020
  62. BRUNO MT, Scalia G, Cassaro N, Boemi S, et al
    Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
    BMC Cancer. 2020;20:444.
    PubMed     Abstract available


  63. ZHANG J, Zhang D, Yang Z, Wang X, et al
    The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    BMC Cancer. 2020;20:443.
    PubMed     Abstract available


  64. GUO HT, Bi XH, Lei T, Lv X, et al
    Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    BMC Cancer. 2020;20:441.
    PubMed     Abstract available


  65. CHEN P, Jiao L, Ren F, Wang DB, et al
    Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    BMC Cancer. 2020;20:423.
    PubMed     Abstract available


  66. EJEGOD DM, Lagheden C, Bhatia R, Pedersen H, et al
    Clinical validation of full genotyping CLART(R) HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
    BMC Cancer. 2020;20:396.
    PubMed     Abstract available


  67. HE X, Liu J, Xiao L, Zhao M, et al
    Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study.
    BMC Cancer. 2020;20:381.
    PubMed     Abstract available


    April 2020
  68. LI C, Li Y, Yan Z, Dai S, et al
    Polymorphisms in endoplasmic reticulum aminopeptidase genes are associated with cervical cancer risk in a Chinese Han population.
    BMC Cancer. 2020;20:341.
    PubMed     Abstract available


  69. SILVA NNT, Santos ACS, Nogueira VM, Carneiro CM, et al
    3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.
    BMC Cancer. 2020;20:323.
    PubMed     Abstract available


  70. TUOHETI Z, Han L, Husaiyin S, Liu X, et al
    RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China.
    BMC Cancer. 2020;20:299.
    PubMed     Abstract available


    March 2020
  71. LIU P, Lin L, Kong Y, Huo Z, et al
    Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
    BMC Cancer. 2020;20:189.
    PubMed     Abstract available


  72. WU Y, Ye S, Goswami S, Pei X, et al
    Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients.
    BMC Cancer. 2020;20:173.
    PubMed     Abstract available


    February 2020
  73. BREWER N, Bartholomew K, Maxwell A, Grant J, et al
    Correction to: Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Maori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine t
    BMC Cancer. 2020;20:163.
    PubMed     Abstract available


  74. EOH KJ, Lee JY, Nam EJ, Kim S, et al
    The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study.
    BMC Cancer. 2020;20:152.
    PubMed     Abstract available


  75. YE S, Sun X, Kang B, Wu F, et al
    The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    BMC Cancer. 2020;20:138.
    PubMed     Abstract available


    January 2020
  76. WENG Q, Jiang J, Haji FM, Nondo LH, et al
    Women's knowledge of and attitudes toward cervical cancer and cervical cancer screening in Zanzibar, Tanzania: a cross-sectional study.
    BMC Cancer. 2020;20:63.
    PubMed     Abstract available


    December 2019
  77. WANG J, Zhang KS, Wang T, Liu Z, et al
    Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.
    BMC Cancer. 2019;19:1219.
    PubMed     Abstract available


  78. WASSIE M, Argaw Z, Tsige Y, Abebe M, et al
    Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study.
    BMC Cancer. 2019;19:1221.
    PubMed     Abstract available


  79. TORRES-POVEDA K, Ruiz-Fraga I, Madrid-Marina V, Chavez M, et al
    High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    BMC Cancer. 2019;19:1205.
    PubMed     Abstract available


  80. BREWER N, Bartholomew K, Maxwell A, Grant J, et al
    Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Maori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of se
    BMC Cancer. 2019;19:1198.
    PubMed     Abstract available


    November 2019
  81. HU Y, Ma Y, Liu J, Cai Y, et al
    LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis.
    BMC Cancer. 2019;19:1157.
    PubMed     Abstract available


  82. ZHAO B, Cao K, Li XT, Zhu HT, et al
    Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.
    BMC Cancer. 2019;19:1115.
    PubMed     Abstract available


  83. CHO SY, Kim S, Son MJ, Kim G, et al
    Dual oxidase 1 and NADPH oxidase 2 exert favorable effects in cervical cancer patients by activating immune response.
    BMC Cancer. 2019;19:1078.
    PubMed     Abstract available


  84. WU F, Zhou J
    CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.
    BMC Cancer. 2019;19:1067.
    PubMed     Abstract available


  85. ZHANG Y, Na R, Wang X
    LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells.
    BMC Cancer. 2019;19:1052.
    PubMed     Abstract available


    October 2019
  86. SOLOMON K, Tamire M, Kaba M
    Predictors of cervical cancer screening practice among HIV positive women attending adult anti-retroviral treatment clinics in Bishoftu town, Ethiopia: the application of a health belief model.
    BMC Cancer. 2019;19:989.
    PubMed     Abstract available


  87. WANG H, Zhang D, Chen Q, Hong Y, et al
    Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions.
    BMC Cancer. 2019;19:986.
    PubMed     Abstract available


    August 2019
  88. ZHU H, Tao X, Zhou L, Sheng B, et al
    Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.
    BMC Cancer. 2019;19:865.
    PubMed     Abstract available


  89. MAPANGA W, Girdler-Brown B, Singh E
    Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination.
    BMC Cancer. 2019;19:845.
    PubMed     Abstract available


  90. NAM KH, Yi SA, Nam G, Noh JS, et al
    Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    BMC Cancer. 2019;19:773.
    PubMed     Abstract available


  91. ALI KE, Mohammed IA, Difabachew MN, Demeke DS, et al
    Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
    BMC Cancer. 2019;19:768.
    PubMed     Abstract available


    June 2019
  92. LEKOANE KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG, et al
    Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    BMC Cancer. 2019;19:563.
    PubMed     Abstract available


  93. VRINTEN C, Gallagher A, Waller J, Marlow LAV, et al
    Cancer stigma and cancer screening attendance: a population based survey in England.
    BMC Cancer. 2019;19:566.
    PubMed     Abstract available


    May 2019
  94. LIU S, Chen J, Yan Z, Dai S, et al
    Polymorphisms in the CCR5 promoter associated with cervical intraepithelial neoplasia in a Chinese Han population.
    BMC Cancer. 2019;19:525.
    PubMed     Abstract available


  95. TUYAERTS S, Van Nuffel AMT, Naert E, Van Dam PA, et al
    PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
    BMC Cancer. 2019;19:506.
    PubMed     Abstract available


  96. SONG Q, Yi F, Zhang Y, Jun Li DK, et al
    CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    BMC Cancer. 2019;19:499.
    PubMed     Abstract available


  97. PARK S, Kim J, Eom K, Oh S, et al
    microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    BMC Cancer. 2019;19:419.
    PubMed     Abstract available


    April 2019
  98. SIDORKIEWICZ I, Zbucka-Kretowska M, Zareba K, Lubowicka E, et al
    Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    BMC Cancer. 2019;19:398.
    PubMed     Abstract available


  99. WUJANTO C, Choo BA, Tan D, Ilancheran A, et al
    Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    BMC Cancer. 2019;19:385.
    PubMed     Abstract available


  100. GAGO J, Paolino M, Arrossi S
    Factors associated with low adherence to cervical cancer follow-up retest among HPV+/ cytology negative women: a study in programmatic context in a low-income population in Argentina.
    BMC Cancer. 2019;19:367.
    PubMed     Abstract available


  101. ARFI A, Hequet D, Bataillon G, Tran-Perennou C, et al
    HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
    BMC Cancer. 2019;19:375.
    PubMed     Abstract available


  102. MIGNOT S, Ringa V, Vigoureux S, Zins M, et al
    Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study.
    BMC Cancer. 2019;19:317.
    PubMed     Abstract available


    March 2019
  103. MURAKAMI N, Kobayashi K, Shima S, Tsuchida K, et al
    A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience.
    BMC Cancer. 2019;19:221.
    PubMed     Abstract available


    February 2019
  104. ABU-SHAWER O, Abu-Shawer M, Hirmas N, Alhouri A, et al
    Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
    BMC Cancer. 2019;19:141.
    PubMed     Abstract available


    January 2019
  105. EGLI-GANY D, Spaar Zographos A, Diebold J, Masserey Spicher V, et al
    Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    BMC Cancer. 2019;19:111.
    PubMed     Abstract available


  106. YE J, Cheng XD, Cheng B, Cheng YF, et al
    MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy.
    BMC Cancer. 2019;19:112.
    PubMed     Abstract available


  107. ITTIAMORNLERT P, Ruengkhachorn I
    Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy.
    BMC Cancer. 2019;19:51.
    PubMed     Abstract available


  108. LIU GC, Zhou YF, Su XC, Zhang J, et al
    Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
    BMC Cancer. 2019;19:24.
    PubMed     Abstract available


  109. ZHANG X, Lv Z, Lou H
    The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
    BMC Cancer. 2019;19:22.
    PubMed     Abstract available


    December 2018
  110. NYAMBE A, Kampen JK, Baboo SK, Van Hal G, et al
    The impact of the social environment on Zambian cervical cancer prevention practices.
    BMC Cancer. 2018;18:1242.
    PubMed     Abstract available


  111. SCHMITZ M, Eichelkraut K, Schmidt D, Zeiser I, et al
    Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
    BMC Cancer. 2018;18:1197.
    PubMed     Abstract available


    November 2018
  112. BU Q, Wang S, Ma J, Zhou X, et al
    The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.
    BMC Cancer. 2018;18:1182.
    PubMed     Abstract available


  113. HUSAIYIN S, Han L, Wang L, Ma C, et al
    Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.
    BMC Cancer. 2018;18:1162.
    PubMed     Abstract available


  114. CARDEN S, van der Watt P, Chi A, Ajayi-Smith A, et al
    A tight balance of Karyopherin beta1 expression is required in cervical cancer cells.
    BMC Cancer. 2018;18:1123.
    PubMed     Abstract available


  115. COUVREUR K, Naert E, De Jaeghere E, Tummers P, et al
    Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.
    BMC Cancer. 2018;18:1101.
    PubMed     Abstract available


  116. DA COSTA AM, Hashim D, Fregnani JHTG, Weiderpass E, et al
    Overall survival and time trends in breast and cervical cancer incidence and mortality in the Regional Health District (RHD) of Barretos, Sao Paulo, Brazil.
    BMC Cancer. 2018;18:1079.
    PubMed     Abstract available


  117. OJAMAA K, Innos K, Baburin A, Everaus H, et al
    Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.
    BMC Cancer. 2018;18:1075.
    PubMed     Abstract available


    October 2018
  118. SUZUKI Y, Tokinaga-Uchiyama A, Mizushima T, Maruyama Y, et al
    Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.
    BMC Cancer. 2018;18:973.
    PubMed     Abstract available


    September 2018
  119. BIGONI-ORDONEZ GD, Ortiz-Sanchez E, Rosendo-Chalma P, Valencia-Gonzalez HA, et al
    Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
    BMC Cancer. 2018;18:928.
    PubMed     Abstract available


  120. ABULIZI G, Zhang YY, Mijiti P, Li H, et al
    Serum Se, Ni, and As are associated with HPV infection and CIN2+ among Uyghur women in rural China.
    BMC Cancer. 2018;18:925.
    PubMed     Abstract available


  121. PARK SH, Lee JY, Nam EJ, Kim S, et al
    Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score.
    BMC Cancer. 2018;18:908.
    PubMed     Abstract available


  122. VANDECASTEELE K, Tummers P, Van Bockstal M, De Visschere P, et al
    EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.
    BMC Cancer. 2018;18:898.
    PubMed     Abstract available


  123. ROTMAN J, Mom CH, Jordanova ES, de Gruijl TD, et al
    'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment.
    BMC Cancer. 2018;18:888.
    PubMed     Abstract available


    August 2018
  124. SHIN JY, Choi KS, Suh M, Park B, et al
    Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea.
    BMC Cancer. 2018;18:810.
    PubMed     Abstract available


    July 2018
  125. GATUMO M, Gacheri S, Sayed AR, Scheibe A, et al
    Women's knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: a cross-sectional study.
    BMC Cancer. 2018;18:745.
    PubMed     Abstract available


    June 2018
  126. PARDINI B, De Maria D, Francavilla A, Di Gaetano C, et al
    MicroRNAs as markers of progression in cervical cancer: a systematic review.
    BMC Cancer. 2018;18:696.
    PubMed     Abstract available


  127. VAN DE SANDE AJM, Koeneman MM, Gerestein CG, Kruse AJ, et al
    TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
    BMC Cancer. 2018;18:655.
    PubMed     Abstract available


  128. GININDZA TG, Sartorius B
    Projected cervical Cancer incidence in Swaziland using three methods and local survey estimates.
    BMC Cancer. 2018;18:639.
    PubMed     Abstract available


    May 2018
  129. MABELELE MM, Materu J, Ng'ida FD, Mahande MJ, et al
    Knowledge towards cervical cancer prevention and screening practices among women who attended reproductive and child health clinic at Magu district hospital, Lake Zone Tanzania: a cross-sectional study.
    BMC Cancer. 2018;18:565.
    PubMed     Abstract available


  130. LOU H, Gharzouzi E, Guerra SP, Domgue JF, et al
    Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.
    BMC Cancer. 2018;18:562.
    PubMed     Abstract available


  131. MABEYA H, Menon S, Weyers S, Naanyu V, et al
    Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.
    BMC Cancer. 2018;18:557.
    PubMed     Abstract available


  132. TEMPFER CB, Tischoff I, Dogan A, Hilal Z, et al
    Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
    BMC Cancer. 2018;18:530.
    PubMed     Abstract available


    April 2018
  133. WANG H, Cheng X, Ye J, Xu X, et al
    Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
    BMC Cancer. 2018;18:487.
    PubMed     Abstract available


  134. JAVED S, Sharma BK, Sood S, Sharma S, et al
    Significance of CD133 positive cells in four novel HPV-16 positive cervical cancer-derived cell lines and biopsies of invasive cervical cancer.
    BMC Cancer. 2018;18:357.
    PubMed     Abstract available


    March 2018
  135. ZACAPALA-GOMEZ AE, Navarro-Tito N, Alarcon-Romero LDC, Ortuno-Pineda C, et al
    Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.
    BMC Cancer. 2018;18:349.
    PubMed     Abstract available


  136. SHI D, Liang Z, Zhang C, Zhang H, et al
    The effect of surgery on the survival status of patients with locally advanced cervical cancer after radiotherapy/chemoradiotherapy: a meta-analysis.
    BMC Cancer. 2018;18:308.
    PubMed     Abstract available


  137. HABTU Y, Yohannes S, Laelago T
    Health seeking behavior and its determinants for cervical cancer among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: community based cross sectional study.
    BMC Cancer. 2018;18:298.
    PubMed     Abstract available


  138. TOUCH S, Oh JK
    Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    BMC Cancer. 2018;18:294.
    PubMed     Abstract available


  139. TRANBERG M, Bech BH, Blaakaer J, Jensen JS, et al
    Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    BMC Cancer. 2018;18:273.
    PubMed     Abstract available


  140. ANWAR SL, Tampubolon G, Van Hemelrijck M, Hutajulu SH, et al
    Determinants of cancer screening awareness and participation among Indonesian women.
    BMC Cancer. 2018;18:208.
    PubMed     Abstract available


    February 2018
  141. COSTA RFA, Longatto-Filho A, de Lima Vazquez F, Pinheiro C, et al
    Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.
    BMC Cancer. 2018;18:126.
    PubMed     Abstract available


    January 2018
  142. PAZ-ZULUETA M, Alvarez-Paredes L, Rodriguez Diaz JC, Paras-Bravo P, et al
    Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.
    BMC Cancer. 2018;18:112.
    PubMed     Abstract available


  143. LI C, Zheng X, Li W, Bai F, et al
    Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    BMC Cancer. 2018;18:61.
    PubMed     Abstract available


  144. MARTINEZ-TORRES AC, Reyes-Ruiz A, Benitez-Londono M, Franco-Molina MA, et al
    IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production.
    BMC Cancer. 2018;18:13.
    PubMed     Abstract available


    December 2017
  145. MOMANY MC, Martinez-Gutierrez J, Soto M, Capurro D, et al
    Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.
    BMC Cancer. 2017;17:847.
    PubMed     Abstract available


  146. OBRZUT B, Kusy M, Semczuk A, Obrzut M, et al
    Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.
    BMC Cancer. 2017;17:840.
    PubMed     Abstract available


  147. HUCHKO MJ, Kahn JG, Smith JS, Hiatt RA, et al
    Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya.
    BMC Cancer. 2017;17:826.
    PubMed     Abstract available


  148. LAI AYT, Perucho JAU, Xu X, Hui ES, et al
    Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.
    BMC Cancer. 2017;17:825.
    PubMed     Abstract available


  149. CHANTIMA W, Thepthai C, Cheunsuchon P, Dharakul T, et al
    EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM.
    BMC Cancer. 2017;17:811.
    PubMed     Abstract available


    November 2017
  150. CAMPOS NG, Tsu V, Jeronimo J, Mvundura M, et al
    Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
    BMC Cancer. 2017;17:791.
    PubMed     Abstract available


  151. ALLEN-LEIGH B, Uribe-Zuniga P, Leon-Maldonado L, Brown BJ, et al
    Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    BMC Cancer. 2017;17:734.
    PubMed     Abstract available


  152. LI S, Wen X
    Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014).
    BMC Cancer. 2017;17:726.
    PubMed     Abstract available


    October 2017
  153. HE S, Liao B, Deng Y, Su C, et al
    MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    BMC Cancer. 2017;17:673.
    PubMed     Abstract available


    September 2017
  154. PARK S, Eom K, Kim J, Bang H, et al
    MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
    BMC Cancer. 2017;17:658.
    PubMed     Abstract available


    August 2017
  155. BREBI P, Ili CG, Andana A, Menzel D, et al
    Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
    BMC Cancer. 2017;17:518.
    PubMed     Abstract available


  156. LI J, Ning NY, Rao QX, Chen R, et al
    Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    BMC Cancer. 2017;17:517.
    PubMed     Abstract available


  157. WANG W, Hou X, Yan J, Shen J, et al
    Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    BMC Cancer. 2017;17:510.
    PubMed     Abstract available


    June 2017
  158. KARAGEORGOPOULOU S, Kostakis ID, Gazouli M, Markaki S, et al
    Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    BMC Cancer. 2017;17:451.
    PubMed     Abstract available


  159. BERRAHO M, Amarti-Riffi A, El-Mzibri M, Bezad R, et al
    HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
    BMC Cancer. 2017;17:435.
    PubMed     Abstract available


  160. XU Y, Zhu L, Liu B, Ru T, et al
    Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
    BMC Cancer. 2017;17:427.
    PubMed     Abstract available


  161. SUN XL, Wang HB, Wang ZQ, Cao TT, et al
    Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial.
    BMC Cancer. 2017;17:416.
    PubMed     Abstract available


  162. HAYASHI N, Takahashi H, Hasegawa Y, Higuchi F, et al
    A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    BMC Cancer. 2017;17:397.
    PubMed     Abstract available


    April 2017
  163. KIM SW, Chun M, Ryu HS, Chang SJ, et al
    Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
    BMC Cancer. 2017;17:297.
    PubMed     Abstract available


  164. WANG W, Li Y, Liu N, Gao Y, et al
    MiR-23b controls ALDH1A1 expression in cervical cancer stem cells.
    BMC Cancer. 2017;17:292.
    PubMed     Abstract available


  165. LI X
    Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
    BMC Cancer. 2017;17:252.
    PubMed     Abstract available


    March 2017
  166. ZHOU Y, Hao Y, Li Y, Li R, et al
    Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.
    BMC Cancer. 2017;17:230.
    PubMed     Abstract available


    February 2017
  167. GAO ZW, Wang HP, Lin F, Wang X, et al
    CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    BMC Cancer. 2017;17:135.
    PubMed     Abstract available


  168. HONG D, Liu J, Hu Y, Lu X, et al
    Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
    BMC Cancer. 2017;17:136.
    PubMed     Abstract available


  169. DE FREITAS LM, Serafim RB, de Sousa JF, Moreira TF, et al
    Photodynamic therapy combined to cisplatin potentiates cell death responses of cervical cancer cells.
    BMC Cancer. 2017;17:123.
    PubMed     Abstract available


    January 2017
  170. GUERRERO-FLORES H, Apresa-Garcia T, Garay-Villar O, Sanchez-Perez A, et al
    A non-invasive tool for detecting cervical cancer odor by trained scent dogs.
    BMC Cancer. 2017;17:79.
    PubMed     Abstract available


    December 2016
  171. ZHANG X, Pan C, Zhou L, Cai Z, et al
    Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.
    BMC Cancer. 2016;16:949.
    PubMed     Abstract available


    November 2016
  172. PAVLIDOU E, Daponte A, Egea R, Dardiotis E, et al
    Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study.
    BMC Cancer. 2016;16:923.
    PubMed     Abstract available


  173. HUIJSMANS CJ, Geurts-Giele WR, Leeijen C, Hazenberg HL, et al
    HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
    BMC Cancer. 2016;16:922.
    PubMed     Abstract available


  174. TRANBERG M, Bech BH, Blaakaer J, Jensen JS, et al
    Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    BMC Cancer. 2016;16:835.
    PubMed     Abstract available


  175. STUQUI B, Conceicao AL, Termini L, Sichero L, et al
    The differential role of HTRA1 in HPV-positive and HPV-negative cervical cell line proliferation.
    BMC Cancer. 2016;16:840.
    PubMed     Abstract available


    October 2016
  176. WOODHEAD C, Cunningham R, Ashworth M, Barley E, et al
    Cervical and breast cancer screening uptake among women with serious mental illness: a data linkage study.
    BMC Cancer. 2016;16:819.
    PubMed     Abstract available


    February 2016
  177. KOENEMAN MM, Kruse AJ, Kooreman LF, Zur Hausen A, et al
    TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
    BMC Cancer. 2016;16:132.
    PubMed     Abstract available


    January 2016
  178. CONSTANTINOU P, Dray-Spira R, Menvielle G
    Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
    BMC Cancer. 2016;16:255.
    PubMed     Abstract available


  179. CHUNG YL, Horng CF, Lee PI, Chen FL, et al
    Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
    BMC Cancer. 2016;16:179.
    PubMed     Abstract available


  180. THARAVICHITKUL E, Lorvidhaya V, Kamnerdsupaphon P, Sukthomya V, et al
    Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
    BMC Cancer. 2016;16:501.
    PubMed     Abstract available


  181. LI L, Song X, Liu R, Li N, et al
    Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    BMC Cancer. 2016;16:403.
    PubMed     Abstract available


  182. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: